mynth
11/2020

MEDIPASS acquired by DWS GROUP

ITALY Health Providers / Outpatient Care / Radiology EV €100–350M

Context

DWS Alternatives Global Limited has acquired 100% of Medipass srl, a leading provider of cancer care and advanced diagnostic imaging services in Italy and the United Kingdom.

MEDIPASS, which reported an EBITDA margin of [members only] in 2017, is valued in this transaction at an EV/EBITDA multiple of 10x–18x, representing a level close to the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Medipass is a leading Italian provider of outsourced medical imaging, nuclear medicine, and advanced radiotherapy services for both public and private healthcare institutions. Headquartered in San Giovanni in Persiceto (Bologna), the company operates through a specialized B2B business model, managing complex diagnostic departments directly within hospitals (in-situ) or via a network of independent diagnostic clinics. Its core value proposition focuses on high-tech clinical outsourcing, encompassing technology procurement, specialized architectural design, medical physics, and ongoing technical operations for advanced equipment like MRI, CT, and PET-CT scanners.

Ent. Value

€100–350M

Equity Value

[members only]

Multiples

EV / Revenue

4x–10x

EV / EBITDA

10x–18x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2017
€25–50M
€5–25M
[members only]
2016
€25–50M
€5–25M
[members only]

Similar deals in Health Providers

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
12/2020MEDIAN KLINIKENPRIORY GROUPUNITED KINGDOMClinics / Hospitals
12/2020FRESENIUSEUGIN GROUPSPAINOutpatient Care
11/2020MEDICA GROUPGLOBAL DIAGNOSTICSIRELANDRadiology
11/2020APHEON (EX ERGON)VIDACURAGERMANYNursing Homes
11/2020L CATTERTONALLIANCE ANIMAL HEALTHUNITED STATESVet Clinics
11/2020ARDIANINOVIE GROUPFRANCELabs (Biology)
10/2020INFRATILQSCAN GROUPAUSTRALIARadiology
10/2020THE VISTRIA GROUP / CENTERBRIDGE PARTNERSHELP AT HOMEUNITED STATESNursing Homes
10/2020KKR / TETHYS INVEST / ARDIAN / CNP ASSURANCES / MERIEUX EQUITY PARTNERSELSANFRANCEClinics / Hospitals
09/2020VAM INVESTMENTSDEMENEGOITALYOphthalmology

REFERENCES

Valuation range: EV €100–350M

Revenue range: €25–50M

EBITDA range: €5–25M

EV/Revenue range: 4x - 10x

EV/EBITDA range: 10x - 18x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of MEDIPASS by DWS GROUP are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: medipass

Acquirer: dws group